Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | rAd-hCD40L |
Trade Name | |
Synonyms | rAd.CD40L|ISF35 |
Drug Descriptions |
rAd-hCD40L is a recombinant adenovirus vector expressing human CD40LG (CD40L), which activates TNFRSF5 (CD40) signaling and leads to apoptosis and growth inhibition in tumor cells (PMID: 19461675). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C2493 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + rAd-hCD40L | Pembrolizumab rAd-hCD40L | 0 | 1 |
rAd-hCD40L | rAd-hCD40L | 0 | 0 |